Search Results - "De Vries, J K"

The CMSSM and NUHM1 after LHC Run 1 by Buchmueller, O., Cavanaugh, R., Roeck, A. De, Dolan, M. J., Ellis, J. R., Flächer, H., Heinemeyer, S., Isidori, G., Marrouche, J., Santos, D. Martínez, Olive, K. A., Rogerson, S., Ronga, F. J., de Vries, K. J., Weiglein, G.

“…We analyze the impact of data from the full Run 1 of the LHC at 7 and 8 TeV on the CMSSM with μ > 0 and < 0 and the NUHM1 with μ > 0 , incorporating the…”
Get full text

The pMSSM10 after LHC run 1 by de Vries, K. J., Bagnaschi, E. A., Buchmueller, O., Cavanaugh, R., Citron, M., De Roeck, A., Dolan, M. J., Ellis, J. R., Flächer, H., Heinemeyer, S., Isidori, G., Malik, S., Marrouche, J., Santos, D. Martínez, Olive, K. A., Sakurai, K., Weiglein, G.

“…We present a frequentist analysis of the parameter space of the pMSSM10, in which the following ten soft SUSY-breaking parameters are specified independently…”
Get full text

Higgs and supersymmetry by Buchmueller, O., Cavanaugh, R., De Roeck, A., Dolan, M. J., Ellis, J. R., Flächer, H., Heinemeyer, S., Isidori, G., Marrouche, J., Martínez Santos, D., Olive, K. A., Rogerson, S., Ronga, F. J., de Vries, K. J., Weiglein, G.

“…Global frequentist fits to the CMSSM and NUHM1 using the MasterCode framework predicted M h ≃119 GeV in fits incorporating the ( g −2) μ constraint and ≃126…”
Get full text

Implications of improved Higgs mass calculations for supersymmetric models by Buchmueller, O., Dolan, M. J., Ellis, J., Hahn, T., Heinemeyer, S., Hollik, W., Marrouche, J., Olive, K. A., Rzehak, H., de Vries, K. J., Weiglein, G.

“…We discuss the allowed parameter spaces of supersymmetric scenarios in light of improved Higgs mass predictions provided by FeynHiggs 2.10.0. The Higgs mass…”
Get full text

The NUHM2 after LHC Run 1 by Buchmueller, O., Cavanaugh, R., Citron, M., De Roeck, A., Dolan, M. J., Ellis, J. R., Flächer, H., Heinemeyer, S., Malik, S., Marrouche, J., Martínez Santos, D., Olive, K. A., de Vries, K. J., Weiglein, G.

“…We make a frequentist analysis of the parameter space of the NUHM2, in which the soft supersymmetry (SUSY)-breaking contributions to the masses of the two…”
Get full text

Caspase-Independent Exposure of Aminophospholipids and Tyrosine Phosphorylation in Bicarbonate Responsive Human Sperm Cells by DE VRIES, K. J, WIEDMER, T, SIMS, P. J, GADELLA, B. M

“…Only capacitated sperm cells are able to fertilize egg cells, and this process is triggered by high levels of bicarbonate. Bicarbonate renders the plasma…”
Get full text

Patient‐reported outcomes in a randomized trial comparing four different treatment strategies in recent‐onset rheumatoid arthritis by van der Kooij, S. M., de Vries‐Bouwstra, J. K., Goekoop‐Ruiterman, Y. P. M., Ewals, J. A. P. M., Han, K. H., Hazes, J. M. W., Kerstens, P. J. S. M., Peeters, A. J., van Zeben, D., Breedveld, F. C., Huizinga, T. W. J., Dijkmans, B. A. C., Allaart, C. F.

“…Objective To investigate the effectiveness of 4 different treatment strategies for recent‐onset rheumatoid arthritis (RA) on 2‐year patient‐reported outcomes,…”
Get full text

Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up by van den Broek, M, Dirven, L, de Vries-Bouwstra, J K, Dehpoor, A J, Goekoop-Ruiterman, Y P M, Gerards, A H, Kerstens, P J S M, Huizinga, T W J, Lems, Wf, Allaart, C F

“…Several prediction models for rapid radiological progression (RRP) in the first year of rheumatoid arthritis have been designed to aid rheumatologists in their…”
Get more information

Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis by Güler-Yüksel, M, Allaart, C F, Goekoop-Ruiterman, Y P M, de Vries-Bouwstra, J K, van Groenendael, J H L M, Mallée, C, de Bois, M H W, Breedveld, F C, Dijkmans, B A C, Lems, W F

“…To evaluate changes in bone mineral density (BMD) in the hands, hip and spine after 1 and 2 years of follow-up, in relation to antirheumatic and antiresorptive…”
Get more information

Anti‐C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single‐centre, cross‐sectional study by Dijkstra, D.J., Liem, S.I.E., Leeuwen, N.M., Fehres, C.M., Vries‐Bouwstra, J.K., Trouw, L.A.

“…Systemic Sclerosis (SSc) is a rheumatic disease characterized by fibrosis in the skin and internal organs, including the lungs, kidneys and gastrointestinal…”
Get full text

Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis by Güler-Yüksel, M, Bijsterbosch, J, Goekoop-Ruiterman, Y P M, Breedveld, F C, Allaart, C F, de Vries-Bouwstra, J K, Dijkmans, B A C, Lems, W F, Ronday, H K, Peeters, A J, de Jonge-Bok, J M

“…Objectives:Osteoporosis is a well-known extra-articular phenomenon in patients with uncontrolled, long-standing rheumatoid arthritis (RA). In the present…”
Get full text

Physical therapy in patients with systemic sclerosis: physical therapists' perspectives on current delivery and educational needs by Liem, SIE, van Leeuwen, NM, Vliet Vlieland, TPM, Boerrigter, GMW, van den Ende, CHM, de Pundert, LAJ, Schriemer, MR, Spierings, J, Vonk, MC, de Vries-Bouwstra, JK

“…To assess the perspectives of physical therapists treating patients with systemic sclerosis (SSc) on their current practice and educational needs. In July…”
Get full text

Supersymmetric dark matter after LHC run 1 by Bagnaschi, E. A., Buchmueller, O., Cavanaugh, R., Citron, M., De Roeck, A., Dolan, M. J., Ellis, J. R., Flächer, H., Heinemeyer, S., Isidori, G., Malik, S., Martínez Santos, D., Olive, K. A., Sakurai, K., de Vries, K. J., Weiglein, G.

“…Different mechanisms operate in various regions of the MSSM parameter space to bring the relic density of the lightest neutralino, χ ~ 1 0 , assumed here to be…”
Get full text

A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study by Visser, K, Goekoop-Ruiterman, Y P M, de Vries-Bouwstra, J K, Ronday, H K, Seys, P E H, Kerstens, P J S M, Huizinga, T W J, Dijkmans, B A C, Allaart, C F

“…To develop a matrix model for the prediction of rapid radiographic progression (RRP) in subpopulations of patients with recent-onset rheumatoid arthritis (RA)…”
Get more information

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis by van der Kooij, S M, Goekoop-Ruiterman, Y P M, de Vries-Bouwstra, J K, Güler-Yüksel, M, Zwinderman, A H, Kerstens, P J S M, van der Lubbe, P A H M, de Beus, W M, Grillet, B A M, Ronday, H K, Huizinga, T W J, Breedveld, F C, Dijkmans, B A C, Allaart, C F

“…To compare the occurrence of drug-free remission, functional ability and radiological damage after 4 years of response-driven treatment according to four…”
Get more information

Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis by van der Kooij, S M, le Cessie, S, Goekoop-Ruiterman, Y P M, de Vries-Bouwstra, J K, van Zeben, D, Kerstens, P J S M, Hazes, J M W, van Schaardenburg, D, Breedveld, F C, Dijkmans, B A C, Allaart, C F

“…To compare the clinical and radiological efficacy of initial vs delayed treatment with methotrexate (MTX) and infliximab (IFX) in patients with recent onset…”
Get more information

Likelihood analysis of supersymmetric SU(5) GUTs by Bagnaschi, E., Costa, J. C., Sakurai, K., Borsato, M., Buchmueller, O., Cavanaugh, R., Chobanova, V., Citron, M., De Roeck, A., Dolan, M. J., Ellis, J. R., Flächer, H., Heinemeyer, S., Isidori, G., Lucio, M., Martínez Santos, D., Olive, K. A., Richards, A., de Vries, K. J., Weiglein, G.

“…We perform a likelihood analysis of the constraints from accelerator experiments and astrophysical observations on supersymmetric (SUSY) models with SU(5)…”
Get full text

Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damage by de Vries-Bouwstra, J K, Goekoop-Ruiterman, Y P M, Wesoly, J, Hulsmans, H J, de Craen, A J M, Breedveld, F C, Dijkmans, B A C, Allaart, C F, Huizinga, T W J

“…Objectives: (1) To assess innate ex vivo production of interleukin 1β (IL1β) and interleukin 1 receptor antagonist (IL1Ra) in patients with recent-onset…”
Get full text

Fine specificity of the anti–citrullinated protein antibody response is influenced by the shared epitope alleles by Verpoort, K. N., Cheung, K., Ioan‐Facsinay, A., van der Helm‐van Mil, A. H. M., de Vries‐Bouwstra, J. K., Allaart, C. F., Drijfhout, J. W., de Vries, R. R. P., Breedveld, F. C., Huizinga, T. W. J., Pruijn, G. J. M., Toes, R. E. M.

“…Objective In classic studies on the genetic background of antibody production, the major histocompatibility complex (MHC) has been shown to act as the most…”
Get full text

Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis by Güler-Yüksel, M, Bijsterbosch, J, Goekoop-Ruiterman, Y P M, de Vries-Bouwstra, J K, Hulsmans, H M J, de Beus, W M, Han, K H, Breedveld, F C, Dijkmans, B A C, Allaart, C F, Lems, W F

“…We examined the effects of four different treatment strategies on bone mineral density (BMD) in patients with recently diagnosed, active rheumatoid arthritis…”
Get more information